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Dental Appliance Treatment for
Obstructive Sleep Apnea*
Andrew S. L. Chan, MBBS; Richard W. W. Lee, MBBS; and
Peter A. Cistulli, MBBS, PhD, FCCP
Oral appliances for the treatment of obstructive sleep apnea (OSA) are worn during sleep to
maintain the patency of the upper airway by increasing its dimensions and reducing its
collapsibility. Oral appliances are a simpler alternative to continuous positive airway pressure
(CPAP). Over the last decade, there has been a significant expansion of the evidence base to
support the use of oral appliances, with robust studies demonstrating their efficacy. This work has
been underpinned by the recognition of the importance of upper airway anatomy in the
pathophysiology of OSA. The updated practice parameters of the American Academy of Sleep
Medicine now recommend their use for mild-to-moderate OSA, or for patients with severe OSA
who are unable to tolerate CPAP or refuse treatment with CPAP. Oral appliances have been
shown to have a beneficial impact on a number of important clinical end points, including the
polysomnographic indexes of OSA, subjective and objective measures of sleepiness, BP, aspects
of neuropsychological functioning, and quality of life. Elucidation of the mechanism of action of
oral appliances has provided insight into the factors that predict treatment response and may
improve the selection of patients for this treatment modality. Longitudinal studies to characterize
the long-term adverse effects of oral appliance use are now beginning to emerge. Although less
efficacious than CPAP for improving the polysomnographic indexes of OSA, oral appliances are
generally preferred by patients. This has the potential to translate to better patient adherence
and may provide an equivalent health outcome. (CHEST 2007; 132:693–699)
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Abbreviations: AHI  apnea-hypopnea index; CPAP  continuous positive airway pressure; OSA  obstructive sleep
apnea; TRD  tongue-retaining device
T he obstructive sleep apnea (OSA) syndrome is acommon condition that is associated with serious
adverse health consequences.1 Since the first de-
scription of this disorder in the medical literature in
1965,2 effective treatments that modify these health
risks have emerged.3 Although continuous positive
airway pressure (CPAP) is the most efficacious treat-
ment,4 it requires the use of a mask interface, sealed
tubing, and a device connected to a power source.
This complexity limits its acceptance by patients and
leads to suboptimal treatment adherence.5–7
Oral appliances are a simpler alternative to CPAP
for the treatment of OSA.8 They are often consid-
ered by patients to be a more acceptable treatment
modality compared to CPAP,9 as they are quiet,
portable, and do not require a power source. While
the role of oral appliances for the treatment of OSA
was unclear in the past, this has changed substan-
tially in the last decade. There is now an increasing
evidence base to support the use of oral appliances in
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clinical practice.10 The purpose of this article is to
provide an overview of the role of dental appliances
for the treatment of OSA, focusing on the develop-
ments that have occurred in three areas of particular
clinical relevance: (1) the clinical effectiveness of oral
appliances for the treatment of OSA; (2) the predic-
tion of oral appliance treatment outcome; and (3) the
adverse effects of oral appliances.
Types of Oral Appliances and Mechanism
of Action
In broad terms, oral appliances can be regarded as
being either mandibular advancement splints or
tongue-retaining devices (TRDs). Mandibular ad-
vancement splints generally attach to the dental
arches and mechanically protrude the mandible.
They are also known as mandibular advancement
devices or mandibular repositioning appliances.
TRDs use suction pressure to maintain the tongue in
a protruded position during sleep. Mandibular ad-
vancement splints therefore require the patient to
have sufficient teeth; whereas TRDs can be used by
edentulous patients. Most research studies have used
mandibular advancement splints, as they represent
the most common type of oral appliance.
Within these categories, there are further varia-
tions in oral appliance design. Some of these differ-
ences relate to the type of construction material,
configuration, type and location of the coupling
mechanism, degree of customization, and the
amount of vertical opening and lateral jaw movement
permitted. As these factors have the potential to
influence the clinical outcome, the design features of
the oral appliance need to be considered when
applying research evidence to clinical practice. Oral
appliances that allow lateral jaw movement and
vertical opening may reduce the risk of adverse
effects and improve patient adherence. It is also
important to take patient factors into account, such
as dentition and the hard-tissue and soft-tissue anat-
omy. The selection of an appropriate design will vary
on a case-by-case basis. Few studies have assessed
the effect of these variations on clinical outcome.
Despite these differences, the aim of all of these
devices is to improve the patency of the upper airway
during sleep by increasing its dimensions11 and
reducing its collapsibility.12 This is mediated by the
anatomic changes that occur as a result of the
mechanical advancement of the mandible or tongue;
however, the activation of upper airway neuromus-
cular reflexes may also be relevant. That these
anatomic changes are not uniformly seen in all
patients may explain differences in the treatment
response.
Recent Advances in Oral Appliance
Research
Clinical Effectiveness of Oral Appliances
Randomized-controlled trials13,14 using a cross-
over design and an inactive acrylic dental plate as a
placebo have confirmed that oral appliances are
effective for the treatment of OSA, across all grades
of severity. Applying rigorous outcome criteria, a
complete response (reduction of the apnea-hypop-
nea index [AHI] to  5 events per hour) can be
expected in approximately 35 to 40% of patients and
a partial response ( 50% reduction in AHI com-
pared to baseline, but residual AHI remaining  5
events per hour) in 25% of patients. Treatment
failure occurs in approximately 35 to 40% of pa-
tients.13,14 Thus, approximately two thirds of patients
can expect a clinically important response to oral
appliance treatment.
Compared to CPAP, oral appliances are less effi-
cacious for improving the polysomnographic indexes
of OSA. In all seven cross-over trials15–21 comparing
oral appliance treatment with CPAP, CPAP achieved
a greater degree of improvement of AHI and oxygen
saturation. Despite this, there were similar improve-
ments in subjective and objective measures of day-
time sleepiness. These comparison studies also indi-
cate that, in general, patients find oral appliances to
be a more acceptable treatment compared to CPAP.
The extent to which a treatment alleviates the health
risk associated with a disease in clinical practice is a
function of its efficacy and the treatment adherence.
The greater acceptance by patients of oral appliances
could result in better treatment adherence and
provide equivalent clinical effectiveness, despite the
lower efficacy of oral appliances for improving the
polysomnographic indexes of OSA.
When results from oral appliance treatment trials
were pooled, an adherence rate of 77% at 1 year was
found.10 Objective adherence data for oral appli-
ances are limited. A study22 using a novel intraoral
monitoring device to assess objective adherence
found that the average use of the oral appliance was
6.8 h per night, which is similar to the self-reported
adherence in other studies.13,20 In contrast, 46% of
patients used CPAP for at least 4 h per night for
 70% of nights.7
The modification of the health risk associated with
OSA is a key goal of treatment. To this end, the
evaluation of the effect of oral appliances on these
clinical end points has been an important new
research focus.
Cardiovascular outcomes represent an important
measure of the clinical impact of treatment for OSA.
Two randomized, placebo-controlled trials13,15 using
intention-to-treat analyses have assessed the effect of
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oral appliance treatment on BP. Both studies showed
a modest reduction in the 24-h BP (2 to 4 mm Hg)
over a period of 1 month13 and 3 months.15 Whether
certain subpopulations are more likely to achieve a
reduction in BP with oral appliance treatment (such
as those patients with excessive daytime sleepiness)
and the impact on metabolic function and other
cardiovascular end points (including endothelial
function and cardiovascular events and mortality) are
issues that remain unresolved. Early indications are
that oral appliance treatment may have a positive
impact.23
The effect of oral appliance treatment on neuro-
psychological functioning has been examined in
studies using inactive oral devices,24 placebo tablets,
and CPAP as comparisons.15 A small-to-moderate
improvement in psychomotor speed was found after
treatment for 1 month with an oral appliance, but
there were no changes in other aspects of neuropsy-
chological functioning.24 Comparisons of the effect
of oral appliances and CPAP on neuropsychological
functioning are conflicting. Although no differences
were reported in one study,17 another study15 found
that oral appliances and CPAP have differing effects
on a range of neuropsychological parameters. The
overall quality of evidence in this area is weak. There
are only a small number of studies using different
neuropsychological parameters as outcome mea-
sures. Work is needed to better define the impact of
oral appliance treatment on neuropsychological
functioning. Improvements in objective measures of
sleepiness using the maintenance of wakefulness
test25 and the multiple sleep latency test13 have been
demonstrated, but there have been no published
studies of the effect of oral appliance treatment on
motor vehicle accident risk or workplace safety.
Oral appliances improve the quality of life of
patients with OSA. When measured using validated
questionnaires (Functional Outcomes of Sleep
Questionnaire or the Short Form 36), quality of life
is improved by oral appliance treatment compared to
a placebo tablet.15 Although the magnitude of this
effect was comparable to that of treatment with
CPAP, another study17 found that treatment with
CPAP was superior. Further placebo-controlled tri-
als are needed to investigate this aspect of oral
appliance treatment. The clinical benefits of oral
appliance treatment are compared to those of CPAP
in Table 1.
Prediction of Oral Appliance Treatment Outcome
It is clear that not all patients are able to achieve a
successful treatment outcome with oral appliances.10
A barrier to their use in clinical practice is the
inability to reliably predict which patients will
achieve a favorable treatment outcome. This can
result in treatment delays and wastage of health
resources. As such, the development of a method for
prospectively predicting the outcome of oral appli-
ance treatment would be of considerable clinical
importance.
Many studies14,26–28 have identified anthropomor-
phic and physiologic predictors of successful oral
appliance treatment outcome. These include female
gender, lower age, lower body mass index, smaller
neck circumference, lower baseline AHI, supine-
dependent OSA, and primary oropharyngeal collapse
of the upper airway during sleep. Various cephalo-
metric predictors of successful oral appliance treat-
ment outcome (such as shorter soft palate, larger
retropalatal airway space, decreased distance be-
tween the hyoid and mandibular plane, narrower
angle from the sella to the nasion to the supramen-
tale point, and wider angle from the sella to the
nasion to the subspinale point) have also been
demonstrated.14,29,30 There are currently no prospec-
tive studies demonstrating the ability to predict the
outcome of oral appliance treatment using these
parameters, either singly or in combination.
Coinciding with an increasing recognition of the
importance of the upper airway anatomy in the
pathophysiology of OSA,31 studies32,33 have focused
on other modalities for assessing the upper airway.
Upper airway imaging during dynamic maneuvers
has provided insight into the relationship between
the functional properties of the upper airway and the
treatment response. In a study by Sanner et al,32
MRI of the upper airway was performed during the
Müller maneuver. The patency of the upper airway
with mandibular advancement was associated with a
successful treatment outcome with an oral appliance,
Table 1—Clinical End Points of Treatment of OSA




Improvement of snoring  
Improvement in AHI  
Improvement in oxygen saturation  
Reduction in sleep fragmentation  
Improvement in sleep architecture  
Improvement in subjective and objective
measures of daytime sleepiness
 




Improvement in quality of life  
Reduction in motor vehicle accident risk ? 
*An indication of the relative efficacy of oral appliances and CPAP is
denoted by  (small benefit),  (moderate benefit), or 
(large benefit). ? denotes an unresolved end point.
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whereas the persistence of upper airway obstruction
following mandibular advancement was associated
with treatment failure. Although this study32 con-
firms that there are anatomic and functional differ-
ences between those who respond to oral appliance
treatment and those who do not, MRI is not a
clinically useful test for selecting patients for oral
appliance treatment due to its high cost and limited
availability.34
Nasopharyngoscopy is a modality for imaging the
upper airway that, unlike MRI, is widely available in
clinical practice and relatively inexpensive.34 A study
by Johal et al33 based selection for oral appliance
treatment on an improvement in airway patency with
mandibular advancement during drug-induced
“sleep” nasopharyngoscopy. Their results suggested
that sleep nasopharyngoscopy may be useful for
improving the outcome of oral appliance treatment,
with 74% in their series of 19 patients achieving an
AHI of  10 events per hour. Acoustic pharyngom-
etry appears to be increasingly used by dental prac-
titioners to predict the outcome of oral appliance
treatment; however, there has been no published
research study that has confirmed its utility for this
role.
Single-night titration studies incorporating poly-
somnography and incremental mandibular advance-
ment, analogous to CPAP titration, have the poten-
tial to be a clinically useful way to predict treatment
efficacy with oral appliances.35,36 At a simpler level,
there are preliminary data to suggest that flow-
volume curves during wakefulness may differ de-
pending on the treatment response to oral applianc-
es.37 The predictors of a favorable response to oral
appliance treatment are summarized in Table 2.
Adverse Effects of Oral Appliances
The advancement of the mandible or tongue,
being the principal mechanism of action of oral
appliances, has the potential to cause adverse effects
(Table 3). Mandibular advancement splints generate
reciprocal forces on the teeth and jaw that can result
in acute symptoms, as well as long-term dental and
skeletal changes. While mandibular advancement
splints are primarily attached to the dental arches,
most extend beyond these and thus apply pressure to
the gums and oral mucosa. The incidence of re-
ported side effects and complications vary signifi-
cantly between studies. This is probably due to
differences in the type of oral appliance used, the
design of the oral appliance, the degree of mandib-
ular advancement, as well as the frequency and
duration of follow-up.
During the acclimatization period, it is common
for adverse effects to develop, which are usually
minor and self-limiting. These include excessive
salivation, mouth dryness, tooth pain, gum irritation,
headaches, and temporomandibular joint discom-
fort. The frequencies of these adverse effects vary
widely, ranging from 6 to 86% of patients.10 Early
recognition and attention to these symptoms are
important, as they have the potential to influence the
patient’s acceptance of treatment.
The long-term adverse effects of oral appliance
treatment have been described in a number of
longitudinal studies. Earlier studies38–40 observed
patients for a median of approximately 2.5 years. In
these studies,38–40 14% of patients using a mandib-
ular advancement splint had occlusal changes when
assessed by a cephalometric radiography. There was
a reduction in overjet by 1 to 3 mm over a 5-year
Table 2—Predictors of a Favorable Response to Oral
Appliance Treatment
Anthropomorphic and physiologic predictors
Female gender
Lower age




Primary oropharyngeal collapse during sleep
Cephalometric predictors
Shorter soft palate
Larger retropalatal airway space
Decreased distance between hyoid and mandibular plane
Narrower angle from the sella to the nasion to the supramentale
point
Wider angle from the sella to the nasion to the subspinale point
Upper airway anatomic predictors
Airway patency on MRI during Müller maneuver following
mandibular advancement
Improvement in airway patency with mandibular advancement
during drug-induced “sleep” nasopharyngoscopy
Single-night titration of mandibular advancement
Successful single-night mandibular advancement titration study











Increase in facial height
Increase in degree of mouth opening
Changes in inclination of incisors
Increase in mandibular plane angle
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period; however, more than half of these patients
were not aware of these changes. It was noted that
these occlusal changes tended to stabilize after the
first 2 years of treatment.38 An increase in the facial
height, an increase in the degree of mouth opening,
and changes in the inclination of the incisors have
also been reported.38–40
More recent studies41,42 have obtained longitudi-
nal data extending up to 7 years. An increase in the
lower facial height, an increase in the mandibular
plane angle, and changes in the occlusion and dental
arch were found. Contrary to earlier studies, the
duration of oral appliance use correlated with the
extent of changes in the bite relationship and man-
dibular posture, suggesting that these changes con-
tinue to progress with time. Another study,43 observ-
ing patients for a mean of 5.4 years, suggested that
the likelihood of long-term occlusal changes could be
predicted by the pretreatment dental characteristics.
Specifically, a smaller change in overjet ( 1 mm) at
follow-up was more common in those who had a
baseline overbite of  3 mm, an overjet of  3 mm,
or in those who had used a soft elastomeric device
rather than a hard acrylic device.
Translating Research Evidence to
Clinical Practice
The recent update of the clinical practice param-
eters of the American Academy of Sleep Medicine
for the treatment of OSA with oral appliances rec-
ognizes the expansion of knowledge in this field. The
new practice parameters state that oral appliances
are indicated for the treatment of mild-to-moderate
OSA in patients who prefer oral appliances to CPAP,
who do not respond to CPAP, who are not suitable
for treatment with CPAP, or for whom treatment
attempts with CPAP are unsuccessful. As CPAP is a
more efficacious treatment, it is recommended that
CPAP be considered before oral appliances for
patients with severe OSA.44
Overall, oral appliances provide effective treat-
ment for approximately two thirds of patients. The
remainder will not achieve a favorable treatment
outcome, at least from a polysomnographic perspec-
tive.10 Given that not all patients will respond to oral
appliance treatment and the potential for a placebo
response, there is a need for all patients to have
objective evaluation of treatment outcome. An initial
clinical assessment and objective overnight monitor-
ing should be performed to confirm the presence of
OSA and to determine its severity. After construction
of the oral appliance and a period of acclimatization,
a clinical review and another objective assessment to
determine the effectiveness of treatment are strongly
recommended. Ideally, the treatment should be
provided by a multidisciplinary team, comprising a
sleep physician and a dental practitioner with exper-
tise in the management of sleep disorders.44 The
dental practitioner has a critical role in the assess-
ment of the suitability of patients for oral appliance
treatment and the construction of customized oral
appliances.
The limitations of oral appliances need to be
considered when making treatment decisions. Oral
appliances have no known therapeutic effect on
central sleep apnea or hypoventilation. When an
immediate treatment response is required (for exam-
ple, when driver safety or occupational safety issues
exist), an oral appliance would be inappropriate as
the period of acclimatization would cause unneces-
sary delay.8 Similarly, if marked oxygen desaturation
occurs during sleep, CPAP would be more appropri-
ate given its superiority in improving oxygen satura-
tion.10
Although there are a range of demographic, an-
thropomorphic, and polysomnographic variables that
have been associated with treatment outcome, it is
not currently possible to identify with certainty
which patients will respond to treatment in clinical
practice. For example, although patients with severe
OSA are less likely to respond to oral appliance
treatment, there are some patients with severe OSA
who will achieve a complete treatment response.10
While characterization of the relationship between
upper airway anatomy and treatment response may
contribute to the understanding of the mechanism of
action of oral appliances, this has yet to be incorpo-
rated into a clinically useful prediction model.
The potential for long-term dental and cephalo-
metric effects highlights the need for regular review
of the patient by a dental practitioner. Although
cephalometric and dental changes with long-term
oral appliance use have been described, their clinical
significance remains uncertain. The occurrence of
these changes does not always warrant cessation of
therapy. The decision as to whether oral appliance
treatment should be continued needs to be individ-
ualized. Follow-up with a sleep physician is also
recommended to monitor the treatment response
and adherence. If symptoms of OSA recur, polysom-
nography should be considered to re-evaluate the
efficacy of treatment.44
Conclusion
Major advances in the field of oral appliances have
provided a solid evidence base for the use of oral
appliances in the clinical management of OSA.
These developments have been reflected in the
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updated practice parameters of the American Acad-
emy of Sleep Medicine, which now recommend the
use of oral appliances for mild-to-moderate OSA, or
for patients with severe OSA who are unable to
tolerate CPAP or refuse treatment with CPAP.
This review article has focused on the develop-
ments that have occurred in three clinically relevant
areas. There is robust evidence of the efficacy of oral
appliances, both in regard to improving polysomno-
graphic indexes as well as modifying the health risk
associated with OSA. The identification of demo-
graphic, anthropomorphic, polysomnographic, and
upper airway anatomic differences between re-
sponders and nonresponders provides insight into
the mechanism of action of oral appliances and may
improve the selection of patients for this treatment
modality. Finally, there are now studies41,42 that
have assessed the long-term safety of oral appliances
in patients followed up for up to 7 years.
As a simpler alternative to CPAP, oral appliances
are often regarded by patients as a more acceptable
treatment option for OSA. This has the potential to
translate to better treatment adherence and equiva-
lent health benefits, despite the lower efficacy of oral
appliances compared to CPAP. Future research
should focus on determining the influence of the
design of oral appliances on clinical outcome, the
development of a clinically reliable method for iden-
tifying those patients who are most likely to achieve
a favorable treatment response, and the character-
ization of factors predisposing to long-term adverse
effects of oral appliance treatment.
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